- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00067288
Meaning-Centered Psychotherapy in Advanced Cancer
August 16, 2006 updated by: National Center for Complementary and Integrative Health (NCCIH)
We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness.
This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
As per Brief Summary
Study Type
Interventional
Enrollment
118
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Memorial Sloan-Kettering Institute for Cancer Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 21 years of age or older;
- English speaking;
- Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma;
- Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City;
Exclusion Criteria:
- Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention;
- Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent;
- Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Educational/Counseling/Training
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: William Breitbart, MD, Memorial Sloan Kettering Cancer Center
- Christopher Gibson, PhD, Project Coordinator Memorial Sloan-Kettering Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2002
Study Completion
March 1, 2006
Study Registration Dates
First Submitted
August 14, 2003
First Submitted That Met QC Criteria
August 14, 2003
First Posted (Estimate)
August 15, 2003
Study Record Updates
Last Update Posted (Estimate)
August 18, 2006
Last Update Submitted That Met QC Criteria
August 16, 2006
Last Verified
August 1, 2006
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21AT001031-01 (U.S. NIH Grant/Contract)
- Breitbart
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
Peking University First HospitalRecruitingBreast Neoplasms、Lung Neoplasms、Pancreatic NeoplasmsChina
-
Hospices Civils de LyonNot yet recruiting
-
GlaxoSmithKlineCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Recruiting
-
Amphia HospitalRecruitingColonic Neoplasms MalignantNetherlands
-
Marquette General Health SystemUpper Michigan Brain Tumor CenterWithdrawnGlioma | MeningiomaUnited States
-
Ain Shams UniversityNot yet recruiting
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedBrain Stem Neoplasms, Primary | Neoplasms, Brain StemUnited States
-
Medical College of WisconsinM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of Chicago and other collaboratorsRecruiting
-
GlaxoSmithKlineRecruitingNeoplasms, ColonSpain, Belgium, Japan, Italy, United Kingdom, Switzerland
Clinical Trials on Meaning-Centered Group Psychotherapy
-
Memorial Sloan Kettering Cancer CenterFordham UniversityCompletedPalliative CareUnited States
-
Fordham UniversityCalvary Hospital, Bronx, NYNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Mayo ClinicNot yet recruitingHematopoietic Stem Cell TransplantUnited States
-
Duke UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Colorectal Cancer | Prostate Cancer | Breast Cancer Stage IV | Thyroid Cancer | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Breast Cancer Stage III | Prostate Cancer Stage III | Prostate Cancer Stage IV | Thyroid Cancer Stage IV | Thyroid Cancer Stage IIIUnited States, Mexico
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRecruitingSolid Tumor | Solid Tumor, Adult | Solid Tumor, Unspecified, AdultUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRecruitingSolid Tumor | Solid Tumor, Adult | Solid Tumor, Unspecified, AdultUnited States, Puerto Rico